Name of Patient A. A. Age 39 y.

o Height 5’2
Diagnosis G8P7 (7007) PU 37 5/7 wks AOG by UTZ, in beginning labor; Gravido Sex Female Weight 53 kg
cardiac functional Class I (arterial septal defect); grandmultiparity
Author M. M. Olmillo Website milkv.co.vu A/N you’re welcome 

MECHANISM OF ADVERSE
DRUG DATA CLASSIFICATION ACTION
INDICATIONS CONTRAINDICATION NURSING RESPONSIBILITIES
EFFECTS
Generic name: Pharmacologic: Anti-inflammatory; General: Contraindicated with CNS: headache, Before:
Mefenamic acid NSAID analgesic, and > relief of hypersensitivity to dizziness, > Check doctor’s order
antipyretic activities moderate pain mefenamic acid, aspirin insomnia > Assess pain score
Trade name/s: related to inhibition of when therapy will allergy, and as treatment > Assess for history of allergies to
Ponstel prostaglandin not exceed 1 wk of perioperative pain with Dermatologic: NSAIDs
synthesis; exact > treatment of coronary artery bypass rash, pruritus, > Educate patient regarding desired
Patient’s dose: mechanisms of action primary grafting sweating and adverse effects
500mg q6o prn Therapeutic: are not known. dysmenorrhea > Educate patient that prolonged use
Analgesic, GI: nausea, GI of drug may damage liver
Maximum dose: antipyretic Precaution: pain, diarrhea,
500 mg Use cautiously with constipation During:
asthma, renal or hepatic > Give drug with food, milk or
Minimum dose: Onset: varies impairment, peptic ulcer GU: dysuria, renal antacids
125 mg disease, GI bleeding, impairment > Do not increase or double the dose,
Peak: 2-4 hr Patient’s actual hypertension, heart follow exactly as prescribed and
Availability: Pregnancy Category indications: failure, pregnancy, Hematologic: indicated
Capsules – Risk: C Duration: 6 hr Mefenamic acid is lactation bleeding, platelet > Administer drug with full glass of
250mg given to patient inhibition with water
Metabolism: hepatic, for relief of acute higher doses, > Do not break, chew or crush
2-4 hr to moderately Interactions: neutropenia capsule and tablet
Route: severe pain > drug-drug: increased > Do not administer with
PO Distribution: crosses risk of Gi bleeds with Respiratory: anticoagulants and other drug that
placenta, enters ASA, anticoagulants, dyspnea, causes GI upset
breast milk other NSAIDs hemoptysis,
> drug-lab test: false- pharyngitis After:
Excretion: feces, urine positive reaction for > Document accordingly
urinary bile using the Other: peripheral > Monitor for adverse effects
Diazo tablet test edema, > Instruct discontinuation of
anaphylactoid medication if adverse effect occurs
reactions to > Symptomatic management for Non
anaphylactic shock serious side effects
> Assess for occurrence of GI ulcers
after taking

Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Lippincott’s Nursing
Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Drug Guide